Combining Structural Biology, Biophysics & AI to Create Better Therapeutics Faster

• Integrate structural, biophysical, and computational data to improve decision-making and accelerate candidate progression
• Leverage AI-powered predictions alongside experimental validation to identify high-quality drug candidates with greater confidence
• Discover how leading organisations are reducing discovery timelines by combining orthogonal technologies across the drug design process

Speakers:

Ilaria Ferlenghi

Associate Director, Senior Scientific Leader Protein Structure & Biochemistry, Vx Discovery Tech

GSK